Exjade 500 mg, dispergierbare Tabletten - 84 Tablette(n) Swissmedic Key 57466011 Registration Holder Novartis Pharma Schweiz AG Name Exjade 500 mg, dispergierbare Tabletten Date of registration 03.11.2005 Introduction of Sequence 03.11.2005 ATC-Classification Deferasirox (V03AC03) Revision date 19.10.2007 WHO WHO-DDD Valid until Index Therapeuticus (BSV) 06.99. Show package size 84 Tablette(n) Index Therapeuticus (Swissmedic) 06.99. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information CI Ex-factory-Price 2677.42 Deductible k.A. Consumer price 2990.35 Feedback FB GTIN 7680574660119 Medication Code Synthetika Pharmacode Disponibility
Composition deferasiroxum 500 mg, crospovidonum, lactosum monohydricum 543.6 mg, cellulosum microcristallinum, povidonum K 30, natrii laurilsulfas, silica colloidalis anhydrica, magnesii stearas, pro compresso corresp. natrium 0.680 mg. Packungsbestandteile Galenic Form Dispersible Tablets Active Agent Dose Deferasirox 500 mg
Inactive agents Dose Cellulosum Microcristallinum Crospovidonum Lactose Monohydrate 543.6 mg Magnesii Stearas Natrii Laurilsulfas Povidonum K 30 Pro Compresso Silica Colloidalis Anhydrica
Source Data was imported : 05.08.2020
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
